No difference in COVID-19 treatment outcomes among current methamphetamine, cannabis and alcohol users
Abstract Background Poor outcomes of COVID-19 have been reported in older males with medical comorbidities including substance use disorder. However, it is unknown whether there is a difference in COVID-19 treatment outcomes between patients who are current cannabis users, excessive alcohol drinkers...
Main Authors: | Ann Rydberg, Christopher A. Dodoo, Terry D. Schneekloth, Osama A. Abulseoud |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-06-01
|
Series: | Journal of Cannabis Research |
Subjects: | |
Online Access: | https://doi.org/10.1186/s42238-023-00193-w |
Similar Items
-
The Combined Effects of Cannabis, Methamphetamine, and HIV on Neurocognition
by: Jeffrey M. Rogers, et al.
Published: (2023-03-01) -
Evaluation of Drug Abuse on Brain Function using Power Spectrum Analysis of Electroencephalogram Signals in Methamphetamine, Opioid, Cannabis, and Multi-Drug Abuser Groups
by: Nasimeh Marvi, et al.
Published: (2023-04-01) -
Methamphetamine use : clinical and forensic aspects /
by: 411191 McPherson, Sandra B., et al.
Published: (2009) -
Executive Functions in Methamphetamine and Heroin Users versus Non-Users
by: Mehrdad Salehi, et al.
Published: (2013-11-01) -
Associations between methamphetamine and alcohol use disorder, suicidal ideation, and lowered quality of life in methamphetamine users
by: Ketsupar Jirakran, et al.
Published: (2023-06-01)